01 1Qilu Pharmaceutical
01 1MARIBAVIR
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-08-22
Pay. Date : 2025-06-20
DMF Number : 42071
Submission : 2025-06-27
Status : Active
Type : II
20
Qilu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MARIBAVIR, with a corresponding US DMF Number 42071.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 22, 2025, and payment made on June 20, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
